Skip to main content
PMC home page
Protein & Cell logoLink to Protein & Cell
. 2011 Dec 17;2(11):889–898. doi: 10.1007/s13238-011-1113-3

c-Jun, at the crossroad of the signaling network

Qinghang Meng 1, Ying Xia 1,✉
PMCID: PMC4875184  PMID: 22180088

Abstract

c-Jun, the most extensively studied protein of the activator protein-1 (AP-1) complex, is involved in numerous cell activities, such as proliferation, apoptosis, survival, tumorigenesis and tissue morphogenesis. Earlier studies focused on the structure and function have led to the identification of c-Jun as a basic leucine zipper (bZIP) transcription factor that acts as homo- or heterodimer, binding to DNA and regulating gene transcription. Later on, it was shown that extracellular signals can induce post-translational modifications of c-Jun, resulting in altered transcriptional activity and target gene expression. More recent work has uncovered multiple layers of a complex regulatory scheme in which c-Jun is able to crosstalk, amplify and integrate different signals for tissue development and disease. One example of such scheme is the autocrine amplification loop, in which signal-induced AP-1 activates the c-Jun gene promoter, while increased c-Jun expression feedbacks to potentiate AP-1 activity. Another example of such scheme, based on recent characterization of gene knockout mice, is that c-Jun integrates signals of several developmental pathways, including EGFR-ERK, EGFR-RhoA-ROCK, and activin B-MAP3K1-JNK for embryonic eyelid closure. After more than two decades of extensive research, c-Jun remains at the center stage of a molecular network with mysterious functional properties, some of which are yet to be discovered. In this article, we will provide a brief historical overview of studies on c-Jun regulation and function, and use eyelid development as an example to illustrate the complexity of c-Jun crosstalking with signaling pathways.

Keywords: mitogen-activated protein kinase kinase kinase 1 (MAP3K1), c-Jun amino-terminal kinases (JNKs), activator protein-1 (AP-1), gene transcription, phosphorylation

References

  1. Adler V., Polotskaya A., Wagner F., Kraft A.S. Affinitypurified c-Jun amino-terminal protein kinase requires serine/threonine phosphorylation for activity. J Biol Chem. 1992;267:17001–17005. [PubMed] [Google Scholar]
  2. Angel P., Allegretto E.A., Okino S.T., Hattori K., Boyle W.J., Hunter T., Karin M. Oncogene jun encodes a sequencespecific trans-activator similar to AP-1. Nature. 1988;332:166–171. doi: 10.1038/332166a0. [DOI] [PubMed] [Google Scholar]
  3. Angel P., Hattori K., Smeal T., Karin M. The jun protooncogene is positively autoregulated by its product, Jun/AP-1. Cell. 1988;55:875–885. doi: 10.1016/0092-8674(88)90143-2. [DOI] [PubMed] [Google Scholar]
  4. Angel P., Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta. 1991;1072:129–157. doi: 10.1016/0304-419x(91)90011-9. [DOI] [PubMed] [Google Scholar]
  5. Atfi A., Djelloul S., Chastre E., Davis R., Gespach C. Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor beta-mediated signaling. J Biol Chem. 1997;272:1429–1432. doi: 10.1074/jbc.272.3.1429. [DOI] [PubMed] [Google Scholar]
  6. Baker S.J., Kerppola T.K., Luk D., Vandenberg M.T., Marshak D. R., Curran T., Abate C. Jun is phosphorylated by several protein kinases at the same sites that are modified in serum-stimulated fibroblasts. Mol Cell Biol. 1992;12:4694–4705. doi: 10.1128/MCB.12.10.4694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Behre G., Whitmarsh A.J., Coghlan M.P., Hoang T., Carpenter C. L., Zhang D.E., Davis R.J., Tenen D.G. c-Jun is a JNK-independent coactivator of the PU. transcription factor. J Biol Chem. 1999;274:4939–4946. doi: 10.1074/jbc.274.8.4939. [DOI] [PubMed] [Google Scholar]
  8. Behrens A., Jochum W., Sibilia M., Wagner E.F. Oncogenic transformation by ras and fos is mediated by c-Jun Nterminal phosphorylation. Oncogene. 2000;19:2657–2663. doi: 10.1038/sj.onc.1203603. [DOI] [PubMed] [Google Scholar]
  9. Behrens A., Sibilia M., Wagner E.F. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat Genet. 1999;21:326–329. doi: 10.1038/6854. [DOI] [PubMed] [Google Scholar]
  10. Bengal E., Ransone L., Scharfmann R., Dwarki V.J., Tapscott S.J., Weintraub H., Verma I.M. Functional antagonism between c-Jun and MyoD proteins: a direct physical association. Cell. 1992;68:507–519. doi: 10.1016/0092-8674(92)90187-H. [DOI] [PubMed] [Google Scholar]
  11. Biddie S.C., John S., Sabo P.J., Thurman R.E., Johnson T.A., Schiltz R.L., Miranda T.B., Sung M.H., Trump S., Lightman S.L., et al. Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding. Mol Cell. 2011;43:145–155. doi: 10.1016/j.molcel.2011.06.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Black E.J., Street A.J., Gillespie D.A. Protein phosphatase 2A reverses phosphorylation of c-Jun specified by the delta domain in vitro: correlation with oncogenic activation and deregulated transactivation activity of v-Jun. Oncogene. 1991;6:1949–1958. [PubMed] [Google Scholar]
  13. Bohmann D. Transcription factor phosphorylation: a link between signal transduction and the regulation of gene expression. Cancer Cells. 1990;2:337–344. [PubMed] [Google Scholar]
  14. Bohmann D., Bos T.J., Admon A., Nishimura T., Vogt P.K., Tjian R. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science. 1987;238:1386–1392. doi: 10.1126/science.2825349. [DOI] [PubMed] [Google Scholar]
  15. Bos T.J., Bohmann D., Tsuchie H., Tjian R., Vogt P.K. v-jun encodes a nuclear protein with enhancer binding properties of AP-1. Cell. 1988;52:705–712. doi: 10.1016/0092-8674(88)90408-4. [DOI] [PubMed] [Google Scholar]
  16. Boyle W.J., Smeal T., Defize L.H., Angel P., Woodgett J.R., Karin M., Hunter T. Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell. 1991;64:573–584. doi: 10.1016/0092-8674(91)90241-P. [DOI] [PubMed] [Google Scholar]
  17. Chi H., Sarkisian M.R., Rakic P., Flavell R.A. Loss of mitogen-activated protein kinase kinase kinase 4 (MEKK4) results in enhanced apoptosis and defective neural tube development. Proc Natl Acad Sci U S A. 2005;102:3846–3851. doi: 10.1073/pnas.0500026102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Christerson L.B., Vanderbilt C.A., Cobb M.H. MEKK1 interacts with alpha-actinin and localizes to stress fibers and focal adhesions. Cell Motil Cytoskeleton. 1999;43:186–198. doi: 10.1002/(SICI)1097-0169(1999)43:3<186::AID-CM2>3.0.CO;2-1. [DOI] [PubMed] [Google Scholar]
  19. Davis R.J. MAPKs: new JNK expands the group. Trends Biochem Sci. 1994;19:470–473. doi: 10.1016/0968-0004(94)90132-5. [DOI] [PubMed] [Google Scholar]
  20. Deak J.C., Templeton D.J. Regulation of the activity of MEK kinase 1 (MEKK1) by autophosphorylation within the kinase activation domain. Biochem J. 1997;322:185–192. doi: 10.1042/bj3220185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Dérijard B., Hibi M., Wu I.H., Barrett T., Su B., Deng T., Karin M., Davis R.J. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell. 1994;76:1025–1037. doi: 10.1016/0092-8674(94)90380-8. [DOI] [PubMed] [Google Scholar]
  22. Devary Y., Gottlieb R.A., Lau L.F., Karin M. Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol Cell Biol. 1991;11:2804–2811. doi: 10.1128/MCB.11.5.2804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Diener K., Wang X.S., Chen C., Meyer C.F., Keesler G., Zukowski M., Tan T.H., Yao Z. Activation of the c-Jun N-terminal kinase pathway by a novel protein kinase related to human germinal center kinase. Proc Natl Acad Sci U S A. 1997;94:9687–9692. doi: 10.1073/pnas.94.18.9687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Dumitru C.D., Ceci J.D., Tsatsanis C., Kontoyiannis D., Stamatakis K., Lin J.H., Patriotis C., Jenkins N.A., Copeland N.G., Kollias G., et al. TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell. 2000;103:1071–1083. doi: 10.1016/S0092-8674(00)00210-5. [DOI] [PubMed] [Google Scholar]
  25. Ellenberger T.E., Brandl C.J., Struhl K., Harrison S.C. The GCN4 basic region leucine zipper binds DNA as a dimer of uninterrupted alpha helices: crystal structure of the protein-DNA complex. Cell. 1992;71:1223–1237. doi: 10.1016/S0092-8674(05)80070-4. [DOI] [PubMed] [Google Scholar]
  26. Findlater G.S., McDougall R.D., Kaufman M.H. Eyelid development, fusion and subsequent reopening in the mouse. J Anat. 1993;183:121–129. [PMC free article] [PubMed] [Google Scholar]
  27. Florin L., Hummerich L., Dittrich B.T., Kokocinski F., Wrobel G., Gack S., Schorpp-Kistner M., Werner S., Hahn M., Lichter P., et al. Identification of novel AP-1 target genes in fibroblasts regulated during cutaneous wound healing. Oncogene. 2004;23:7005–7017. doi: 10.1038/sj.onc.1207938. [DOI] [PubMed] [Google Scholar]
  28. Franklin C.C., McCulloch A.V., Kraft A.S. In vitro association between the Jun protein family and the general transcription factors, TBP and TFIIB. Biochem J. 1995;305:967–974. doi: 10.1042/bj3050967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Franklin C.C., Sanchez V., Wagner F., Woodgett J.R., Kraft A. S. Phorbol ester-induced amino-terminal phosphorylation of human JUN but not JUNB regulates transcriptional activation. Proc Natl Acad Sci U S A. 1992;89:7247–7251. doi: 10.1073/pnas.89.15.7247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Gage P.J., Qian M., Wu D., Rosenberg K.I. The canonical Wnt signaling antagonist DKK2 is an essential effector of PITX2 function during normal eye development. Dev Biol. 2008;317:310–324. doi: 10.1016/j.ydbio.2008.02.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Gallagher E.D., Gutowski S., Sternweis P.C., Cobb M.H. RhoA binds to the amino terminus of MEKK1 and regulates its kinase activity. J Biol Chem. 2004;279:1872–1877. doi: 10.1074/jbc.M309525200. [DOI] [PubMed] [Google Scholar]
  32. Geh E., Meng Q., Mongan M., Wang J., Takatori A., Zheng Y., Puga A., Lang R.A., Xia Y. Mitogen-activated protein kinase kinase kinase 1 (MAP3K1) integrates developmental signals for eyelid closure. Proc Natl Acad Sci USA. 2011;108:17349–17354. doi: 10.1073/pnas.1102297108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Grose R. Epithelial migration: open your eyes to c-Jun. Curr Biol. 2003;13:R678–R680. doi: 10.1016/S0960-9822(03)00607-9. [DOI] [PubMed] [Google Scholar]
  34. Guo Z., Clydesdale G., Cheng J., Kim K., Gan L., McConkey D.J., Ullrich S.E., Zhuang Y., Su B. Disruption of Mekk2 in mice reveals an unexpected role for MEKK2 in modulating T-cell receptor signal transduction. Mol Cell Biol. 2002;22:5761–5768. doi: 10.1128/MCB.22.16.5761-5768.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Hai T.W., Liu F., Allegretto E.A., Karin M., Green M.R. A family of immunologically related transcription factors that includes multiple forms of ATF and AP-1. Genes Dev. 1988;2:1216–1226. doi: 10.1101/gad.2.10.1216. [DOI] [PubMed] [Google Scholar]
  36. Haluska F.G., Huebner K., Isobe M., Nishimura T., Croce C.M., Vogt P.K. Localization of the human JUN protooncogene to chromosome region 1p31–32. Proc Natl Acad Sci U S A. 1988;85:2215–2218. doi: 10.1073/pnas.85.7.2215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Harshman K.D., Moye-Rowley W.S., Parker C.S. Transcriptional activation by the SV40 AP-1 recognition element in yeast is mediated by a factor similar to AP-1 that is distinct from GCN4. Cell. 1988;53:321–330. doi: 10.1016/0092-8674(88)90393-5. [DOI] [PubMed] [Google Scholar]
  38. Hibi M., Lin A., Smeal T., Minden A., Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 1993;7:2135–2148. doi: 10.1101/gad.7.11.2135. [DOI] [PubMed] [Google Scholar]
  39. Huang J., Dattilo L.K., Rajagopal R., Liu Y., Kaartinen V., Mishina Y., Deng C.X., Umans L., Zwijsen A., Roberts A.B., et al. FGF-regulated BMP signaling is required for eyelid closure and to specify conjunctival epithelial cell fate. Development. 2009;136:1741–1750. doi: 10.1242/dev.034082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Hüser M., Luckett J., Chiloeches A., Mercer K., Iwobi M., Giblett S., Sun X.M., Brown J., Marais R., Pritchard C. MEK kinase activity is not necessary for Raf-1 function. EMBO J. 2001;20:1940–1951. doi: 10.1093/emboj/20.8.1940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Johnson G.L., Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 2002;298:1911–1912. doi: 10.1126/science.1072682. [DOI] [PubMed] [Google Scholar]
  42. Johnson R.S., van Lingen B., Papaioannou V.E., Spiegelman B.M. A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture. Genes Dev. 1993;7:1309–1317. doi: 10.1101/gad.7.7b.1309. [DOI] [PubMed] [Google Scholar]
  43. Karin M. Signal transduction and gene control. Curr Opin Cell Biol. 1991;3:467–473. doi: 10.1016/0955-0674(91)90075-A. [DOI] [PubMed] [Google Scholar]
  44. Karin M., Liu Z., Zandi E. AP-1 function and regulation. Curr Opin Cell Biol. 1997;9:240–246. doi: 10.1016/S0955-0674(97)80068-3. [DOI] [PubMed] [Google Scholar]
  45. Kuan C.Y., Yang D.D., Samanta Roy D.R., Davis R.J., Rakic P., Flavell R.A. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron. 1999;22:667–676. doi: 10.1016/S0896-6273(00)80727-8. [DOI] [PubMed] [Google Scholar]
  46. Kyriakis J.M., Banerjee P., Nikolakaki E., Dai T., Rubie E.A., Ahmad M.F., Avruch J., Woodgett J.R. The stress-activated protein kinase subfamily of c-Jun kinases. Nature. 1994;369:156–160. doi: 10.1038/369156a0. [DOI] [PubMed] [Google Scholar]
  47. Lamph W.W., Wamsley P., Sassone-Corsi P., Verma I.M. Induction of proto-oncogene JUN/AP-1 by serum and TPA. Nature. 1988;334:629–631. doi: 10.1038/334629a0. [DOI] [PubMed] [Google Scholar]
  48. Landschulz W.H., Johnson P.F., McKnight S.L. The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science. 1988;240:1759–1764. doi: 10.1126/science.3289117. [DOI] [PubMed] [Google Scholar]
  49. Lange-Carter C.A., Pleiman C.M., Gardner A.M., Blumer K.J., Johnson G.L. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science. 1993;260:315–319. doi: 10.1126/science.8385802. [DOI] [PubMed] [Google Scholar]
  50. Lee W., Mitchell P., Tjian R. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell. 1987;49:741–752. doi: 10.1016/0092-8674(87)90612-X. [DOI] [PubMed] [Google Scholar]
  51. Li G., Gustafson-Brown C., Hanks S.K., Nason K., Arbeit J.M., Pogliano K., Wisdom R.M., Johnson R.S. c-Jun is essential for organization of the epidermal leading edge. Dev Cell. 2003;4:865–877. doi: 10.1016/S1534-5807(03)00159-X. [DOI] [PubMed] [Google Scholar]
  52. Li M., Ge Q., Wang W., Wang J., Lu Z. c-Jun binding site identification in K562 cells. J Genetics Genomics (Yi chuan xue bao) 2011;38:235–242. doi: 10.1016/j.jgg.2011.05.004. [DOI] [PubMed] [Google Scholar]
  53. Lin A., Frost J., Deng T., Smeal T., al-Alawi N., Kikkawa U., Hunter T., Brenner D., Karin M. Casein kinase II is a negative regulator of c-Jun DNA binding and AP-1 activity. Cell. 1992;70:777–789. doi: 10.1016/0092-8674(92)90311-Y. [DOI] [PubMed] [Google Scholar]
  54. Lin A., Minden A., Martinetto H., Claret F.X., Lange-Carter C., Mercurio F., Johnson G.L., Karin M. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science. 1995;268:286–290. doi: 10.1126/science.7716521. [DOI] [PubMed] [Google Scholar]
  55. Luetteke N.C., Qiu T.H., Peiffer R.L., Oliver P., Smithies O., Lee D.C. TGF alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell. 1993;73:263–278. doi: 10.1016/0092-8674(93)90228-I. [DOI] [PubMed] [Google Scholar]
  56. Maki Y., Bos T.J., Davis C., Starbuck M., Vogt P.K. Avian sarcoma virus 17 carries the jun oncogene. Proc Natl Acad Sci U S A. 1987;84:2848–2852. doi: 10.1073/pnas.84.9.2848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. McHenry J.Z., Leon A., Matthaei K.I., Cohen D.R. Overexpression of fra-2 in transgenic mice perturbs normal eye development. Oncogene. 1998;17:1131–1140. doi: 10.1038/sj.onc.1202044. [DOI] [PubMed] [Google Scholar]
  58. Minden A., Lin A., McMahon M., Lange-Carter C., Derijard B., Davis R.J., Johnson G.L., Karin M. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science. 1994;266:1719–1723. doi: 10.1126/science.7992057. [DOI] [PubMed] [Google Scholar]
  59. Mine N., Iwamoto R., Mekada E. HB-EGF promotes epithelial cell migration in eyelid development. Development. 2005;132:4317–4326. doi: 10.1242/dev.02030. [DOI] [PubMed] [Google Scholar]
  60. Mordret G. MAP kinase kinase: a node connecting multiple pathways. Biology of the cell / under the auspices of the European Cell Biology Organization. 1993;79:193–207. doi: 10.1016/0248-4900(93)90138-5. [DOI] [PubMed] [Google Scholar]
  61. Nakamura T., Datta R., Kharbanda S., Kufe D. Regulation of jun and fos gene expression in human monocytes by the macrophage colony-stimulating factor. Cell Growth Differ. 1991;2:267–272. [PubMed] [Google Scholar]
  62. Naoe H., Araki K., Nagano O., Kobayashi Y., Ishizawa J., Chiyoda T., Shimizu T., Yamamura K., Sasaki Y., Saya H., et al. The anaphase-promoting complex/cyclosome activator Cdh1 modulates Rho GTPase by targeting p190 RhoGAP for degradation. Mol Cell Biol. 2010;30:3994–4005. doi: 10.1128/MCB.01358-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Nikolakaki E., Coffer P.J., Hemelsoet R., Woodgett J.R., Defize L.H. Glycogen synthase kinase 3 phosphorylates Jun family members in vitro and negatively regulates their transactivating potential in intact cells. Oncogene. 1993;8:833–840. [PubMed] [Google Scholar]
  64. Papavassiliou A.G., Chavrier C., Bohmann D. Phosphorylation state and DNA-binding activity of c-Jun depend on the intracellular concentration of binding sites. Proc Natl Acad Sci U S A. 1992;89:11562–11565. doi: 10.1073/pnas.89.23.11562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Pertovaara L., Sistonen L., Bos T.J., Vogt P.K., Keski-Oja J., Alitalo K. Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation. Mol Cell Biol. 1989;9:1255–1262. doi: 10.1128/MCB.9.3.1255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Pomérance M., Multon M.C., Parker F., Venot C., Blondeau J.P., Tocqué B., Schweighoffer F. Grb2 interaction with MEK-kinase 1 is involved in regulation of Jun-kinase activities in response to epidermal growth factor. J Biol Chem. 1998;273:24301–24304. doi: 10.1074/jbc.273.38.24301. [DOI] [PubMed] [Google Scholar]
  67. Providence K.M., Higgins P.J. PAI-1 expression is required for epithelial cell migration in two distinct phases of in vitro wound repair. J Cell Physiol. 2004;200:297–308. doi: 10.1002/jcp.20016. [DOI] [PubMed] [Google Scholar]
  68. Quantin B., Breathnach R. Epidermal growth factor stimulates transcription of the c-jun proto-oncogene in rat fibroblasts. Nature. 1988;334:538–539. doi: 10.1038/334538a0. [DOI] [PubMed] [Google Scholar]
  69. Rauscher F.J., 3rd, Cohen D.R., Curran T., Bos T.J., Vogt P.K., Bohmann D., Tjian R., Franza B.R., Jr. Fos-associated protein p39 is the product of the jun proto-oncogene. Science. 1988;240:1010–1016. doi: 10.1126/science.3130660. [DOI] [PubMed] [Google Scholar]
  70. Rauscher F.J., 3rd, Voulalas P.J., Franza B.R., Jr, Curran T. Fos and Jun bind cooperatively to the AP-1 site: reconstitution in vitro. Genes Dev. 1988;2:1687–1699. doi: 10.1101/gad.2.12b.1687. [DOI] [PubMed] [Google Scholar]
  71. Ryder K., Lau L.F., Nathans D. A gene activated by growth factors is related to the oncogene v-jun. Proc Natl Acad Sci U S A. 1988;85:1487–1491. doi: 10.1073/pnas.85.5.1487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Ryder K., Nathans D. Induction of protooncogene c-jun by serum growth factors. Proc Natl Acad Sci U S A. 1988;85:8464–8467. doi: 10.1073/pnas.85.22.8464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Schlesinger T.K., Fanger G.R., Yujiri T., Johnson G.L. The TAO of MEKK. Front Biosci. 1998;3:D1181–D1186. doi: 10.2741/a354. [DOI] [PubMed] [Google Scholar]
  74. Schumacher M.A., Goodman R.H., Brennan R.G. The structure of a CREB bZIP.somatostatin CRE complex reveals the basis for selective dimerization and divalent cation-enhanced DNA binding. J Biol Chem. 2000;275:35242–35247. doi: 10.1074/jbc.M007293200. [DOI] [PubMed] [Google Scholar]
  75. Shaulian E., Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol. 2002;4:E131–E136. doi: 10.1038/ncb0502-e131. [DOI] [PubMed] [Google Scholar]
  76. Sherman M.L., Stone R.M., Datta R., Bernstein S.H., Kufe D. W. Transcriptional and post-transcriptional regulation of cjun expression during monocytic differentiation of human myeloid leukemic cells. J Biol Chem. 1990;265:3320–3323. [PubMed] [Google Scholar]
  77. Short N.J. Regulation of transcription. Are some controlling factors more equal than others? Nature. 1987;326:740–741. doi: 10.1038/326740a0. [DOI] [PubMed] [Google Scholar]
  78. Siow Y.L., Kalmar G.B., Sanghera J.S., Tai G., Oh S.S., Pelech S.L. Identification of two essential phosphorylated threonine residues in the catalytic domain of Mekk1. Indirect activation by Pak3 and protein kinase C. J Biol Chem. 1997;272:7586–7594. doi: 10.1074/jbc.272.12.7586. [DOI] [PubMed] [Google Scholar]
  79. Smeal T., Binetruy B., Mercola D., Grover-Bardwick A., Heidecker G., Rapp U.R., Karin M. Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73. Mol Cell Biol. 1992;12:3507–3513. doi: 10.1128/MCB.12.8.3507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Smeal T., Binetruy B., Mercola D.A., Birrer M., Karin M. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature. 1991;354:494–496. doi: 10.1038/354494a0. [DOI] [PubMed] [Google Scholar]
  81. Soh J.W., Mao Y., Liu L., Thompson W.J., Pamukcu R., Weinstein I.B. Protein kinase G activates the JNK1 pathway via phosphorylation of MEKK1. J Biol Chem. 2001;276:16406–16410. doi: 10.1074/jbc.C100079200. [DOI] [PubMed] [Google Scholar]
  82. Su Y.C., Han J., Xu S., Cobb M., Skolnik E.Y. NIK is a new Ste20-related kinase that binds NCK and MEKK1 and activates the SAPK/JNK cascade via a conserved regulatory domain. EMBO J. 1997;16:1279–1290. doi: 10.1093/emboj/16.6.1279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Sutherland C., Renaux B.S., McKay D.J., Walsh M.P. Phosphorylation of caldesmon by smooth-muscle casein kinase II. J Muscle Res Cell Motil. 1994;15:440–456. doi: 10.1007/BF00122118. [DOI] [PubMed] [Google Scholar]
  84. Takatori A., Geh E., Chen L., Zhang L., Meller J., Xia Y. Differential transmission of MEKK1 morphogenetic signals by JNK1 and JNK2. Development. 2008;135:23–32. doi: 10.1242/dev.007120. [DOI] [PubMed] [Google Scholar]
  85. Thumkeo D., Shimizu Y., Sakamoto S., Yamada S., Narumiya S. ROCK-I and ROCK-II cooperatively regulate closure of eyelid and ventral body wall in mouse embryo. Genes Cells. 2005;10:825–834. doi: 10.1111/j.1365-2443.2005.00882.x. [DOI] [PubMed] [Google Scholar]
  86. Tobiume K., Matsuzawa A., Takahashi T., Nishitoh H., Morita K., Takeda K., Minowa O., Miyazono K., Noda T., Ichijo H. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep. 2001;2:222–228. doi: 10.1093/embo-reports/kve046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Toda T., Shimanuki M., Yanagida M. Fission yeast genes that confer resistance to staurosporine encode an AP-1-like transcription factor and a protein kinase related to the mammalian ERK1/MAP2 and budding yeast FUS3 and KSS1 kinases. Genes Dev. 1991;5:60–73. doi: 10.1101/gad.5.1.60. [DOI] [PubMed] [Google Scholar]
  88. Uda M., Ottolenghi C., Crisponi L., Garcia J.E., Deiana M., Kimber W., Forabosco A., Cao A., Schlessinger D., Pilia G. Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development. Hum Mol Genet. 2004;13:1171–1181. doi: 10.1093/hmg/ddh124. [DOI] [PubMed] [Google Scholar]
  89. Wagner E.F., Schonthaler H.B., Guinea-Viniegra J., Tschachler E. Psoriasis: what we have learned from mouse models. Nat Rev Rheumatol. 2010;6:704–714. doi: 10.1038/nrrheum.2010.157. [DOI] [PubMed] [Google Scholar]
  90. Wolter S., Doerrie A., Weber A., Schneider H., Hoffmann E., von der Ohe J., Bakiri L., Wagner E.F., Resch K., Kracht M. c-Jun controls histone modifications, NF-kappaB recruitment, and RNA polymerase II function to activate the ccl2 gene. Mol Cell Biol. 2008;28:4407–4423. doi: 10.1128/MCB.00535-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Xia Y., Wu Z., Su B., Murray B., Karin M. JNKK1 organizes a MAP kinase module through specific and sequential interactions with upstream and downstream components mediated by its amino-terminal extension. Genes Dev. 1998;12:3369–3381. doi: 10.1101/gad.12.21.3369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Xu S., Robbins D.J., Christerson L.B., English J.M., Vanderbilt C. A., Cobb M.H. Cloning of rat MEK kinase 1 cDNA reveals an endogenous membrane-associated 195-kDa protein with a large regulatory domain. Proc Natl Acad Sci U S A. 1996;93:5291–5295. doi: 10.1073/pnas.93.11.5291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Yan M., Dai T., Deak J.C., Kyriakis J.M., Zon L.I., Woodgett J.R., Templeton D.J. Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1. Nature. 1994;372:798–800. doi: 10.1038/372798a0. [DOI] [PubMed] [Google Scholar]
  94. Yang J., Boerm M., McCarty M., Bucana C., Fidler I.J., Zhuang Y., Su B. Mekk3 is essential for early embryonic cardiovascular development. Nat Genet. 2000;24:309–313. doi: 10.1038/73550. [DOI] [PubMed] [Google Scholar]
  95. Yu Z., Bhandari A., Mannik J., Pham T., Xu X., Andersen B. Grainyhead-like factor Get1/Grhl3 regulates formation of the epidermal leading edge during eyelid closure. Dev Biol. 2008;319:56–67. doi: 10.1016/j.ydbio.2008.04.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Yujiri T., Ware M., Widmann C., Oyer R., Russell D., Chan E., Zaitsu Y., Clarke P., Tyler K., Oka Y., et al. MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-kappa B activation. Proc Natl Acad Sci U S A. 2000;97:7272–7277. doi: 10.1073/pnas.130176697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Zenz R., Scheuch H., Martin P., Frank C., Eferl R., Kenner L., Sibilia M., Wagner E.F. c-Jun regulates eyelid closure and skin tumor development through EGFR signaling. Dev Cell. 2003;4:879–889. doi: 10.1016/S1534-5807(03)00161-8. [DOI] [PubMed] [Google Scholar]
  98. Zhang L., Deng M., Parthasarathy R., Wang L., Mongan M., Molkentin J.D., Zheng Y., Xia Y. MEKK1 transduces activin signals in keratinocytes to induce actin stress fiber formation and migration. Mol Cell Biol. 2005;25:60–65. doi: 10.1128/MCB.25.1.60-65.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Zhang L., Wang W., Hayashi Y., Jester J.V., Birk D.E., Gao M., Liu C.Y., Kao W.W., Karin M., Xia Y. A role for MEK kinase 1 in TGF-beta/activin-induced epithelium movement and embryonic eyelid closure. EMBO J. 2003;22:4443–4454. doi: 10.1093/emboj/cdg440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Zhang Y., Neo S.Y., Wang X., Han J., Lin S.C. Axin forms a complex with MEKK1 and activates c-Jun NH(2)-terminal kinase/stress-activated protein kinase through domains distinct from Wnt signaling. J Biol Chem. 1999;274:35247–35254. doi: 10.1074/jbc.274.49.35247. [DOI] [PubMed] [Google Scholar]

Articles from Protein & Cell are provided here courtesy of Oxford University Press

RESOURCES